Connect Biopharm Llc

This study tests if adding rademikibart to standard care can reduce treatment failures during COPD flare-ups in people with type 2 inflammation. About 160 adults who smoke or used to smoke and have had a recent severe flare-up will receive either the drug or a placebo. The main g…

This study tests whether adding rademikibart to standard asthma care can reduce treatment failures during acute asthma attacks. About 160 adults and teens with asthma and type 2 inflammation will receive either the drug or a placebo. The main goal is to see if fewer people need h…